Grace Therapeutics, Inc. (GRCE) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $5.38M | -53.4% |
| 2024 | $11.56M | +3.5% |
| 2023 | $11.17M | -45.1% |
| 2022 | $20.35M | +199.4% |
| 2021 | $6.80M | -31.0% |
| 2020 | $9.86M | -61.9% |
| 2019 | $25.85M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $5.38M | -53.4% |
| 2024 | $11.56M | +3.5% |
| 2023 | $11.17M | -45.1% |
| 2022 | $20.35M | +199.4% |
| 2021 | $6.80M | -31.0% |
| 2020 | $9.86M | -61.9% |
| 2019 | $25.85M | — |